Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty over how the president-elect will reconcile starkly different philosophies among the leaders of his team.
Trump announced Thursday he'll nominate Robert F. Kennedy Jr. to be secretary of the Health and Human Services Department, after saying during his campaign he'd let the anti-vaccine activist "go wild" on medicines, food, and health.
Should Kennedy win Senate confirmation, his critics say a radical antiestablishment medical movement with roots in past centuries would take power, threatening the achievements of a science-based public health order painstakingly built since World War II.
Trump said in a post on the social platform X that "Americans have been crushed by the industrial food complex and drug companies who have engaged in deception, misinformation, and disinformation when it comes to Public Health," echoing Kennedy's complaints about the medical establishment. The former Democratic presidential candidate will "end the Chronic Disease epidemic" and "Make American Great and Healthy Again!" Trump wrote.
If Kennedy makes good on his vision for transforming public health, childhood vaccine mandates could wither. New vaccines might never win approval, even as the FDA allows dangerous or inefficient therapies onto the market. Agency websites could trumpet unproven or debunked health ideas. And if Trump's plan to weaken civil service rights goes through, anyone who questions these decisions could be summarily fired.
"Never has anybody like RFK Jr. gotten anywhere close to the position he may be in to actually shape policy," said Lewis Grossman, a law professor at American University and the author of "Choose Your Medicine," a history of U.S. public health.
Kennedy and an adviser Calley Means, a health care entrepreneur, say dramatic changes are needed because of the high levels of chronic disease in the United States. Government agencies have corruptly tolerated or promoted unhealthy diets and dangerous drugs and vaccines, they say.
Means and Kennedy did not respond to requests for comment. Four conservative members of the first Trump health bureaucracy spoke on condition of anonymity. They eagerly welcomed the former president's return but voiced few opinions about specific policies. Days after last week's election, RFK Jr. announced that the Trump administration would immediately fire and replace 600 National Institutes of Health officials. He set up a website seeking crowdsourced nominees for federal appointments, with a host of vaccination foes and chiropractors among the early favorites.
At meetings last week at Mar-a-Lago involving Elon Musk, Tucker Carlson, Donald Trump Jr., Kennedy, and Means, according to Politico, some candidates for leading health posts included Jay Bhattacharya, a Stanford University scientist who opposed covid lockdowns; Florida Surgeon General Joseph Ladapo, who opposes mRNA covid vaccines and rejected well-established disease control practices during a measles outbreak; Johns Hopkins University surgeon Marty Makary; and Means' sister, Stanford-trained surgeon and health guru Casey Means.
All are mavericks of a sort, though their ideas are not uniform. Yet the notion that they could elbow aside a century of science-based health policy is profoundly troubling to many health professionals. They see Kennedy's presence at the heart of the Trump transition as a triumph of the "medical freedom" movement, which arose in opposition to the Progressive Era idea that experts should guide health care policy and practices.
It could represent a turning away from the expectation that mainstream doctors be respected for their specialized knowledge, said Howard Markel, an emeritus professor of pediatrics and history at the University of Michigan, who began his clinical career treating AIDS patients and ended it after suffering a yearlong bout of long covid.
"We've gone back to the idea of 'every man his own doctor,'" he said, referring to a phrase that gained currency in the 19th century. It was a bad idea then and it's even worse now, he said.
"What does that do to the morale of scientists?" Markel asked. The public health agencies, largely a post-WWII legacy, are "remarkable institutions, but you can screw up these systems, not just by defunding them but by deflating the true patriots who work in them."
FDA Commissioner Robert Califf told a conference on Nov. 12 that he worried about mass firings at the FDA. "I'm biased, but I feel like the FDA is sort of at peak performance right now," he said. At a conference the next day, CDC Director Mandy Cohen reminded listeners of the horrors of vaccine-preventable diseases like measles and polio. "I don't want to have to see us go backward in order to remind ourselves that vaccines work," she said.
Stocks of some the biggest vaccine developers fell after news outlets led by Politico reported that the RFK pick was expected. Moderna, the developer of one of the most popular covid-19 vaccines, closed down 5.6%. Pfizer, another covid vaccine manufacturer, fell 2.6%. GSK, the producer of vaccines protecting against respiratory syncytial virus, hepatitis A and B, rotavirus, and influenza, fell just over 2%. French drug company Sanofi, whose website boasts its products vaccinate over 500 million annually, tumbled nearly 3.5%.
Exodus From the Agencies?
With uncertainty over the direction of their agencies, many older scientists at the NIH, FDA, and Centers for Disease Control and Prevention are considering retirement, said a senior NIH scientist who spoke on the condition of anonymity for fear of losing his job.
"Everybody I talk to sort of takes a deep breath and says, 'It doesn't look good,'" the official said.
"I hear of many people getting CVs ready," said Arthur Caplan, a professor of bioethics at New York University. They include two of his former students who now work at the FDA, Caplan said.
Others, such as Georges Benjamin, executive director of the American Public Health Association, have voiced wait-and-see attitudes. "We worked with the Trump administration last time. There were times things worked reasonably well," he said, "and times when things were chaotic, particularly during covid." Any wholesale deregulation efforts in public health would be politically risky for Trump, he said, because when administrations "screw things up, people get sick and die."
At the FDA, at least, "it's very hard to make seismic changes," former FDA chief counsel Dan Troy said.
But the administration could score easy libertarian-tinged wins by, for example, telling its new FDA chief to reverse the agency's refusal to approve the psychedelic drug MDMA from the company Lykos. Access to psychedelics to treat post-traumatic stress disorder has grabbed the interest of many veterans. Vitamins and supplements, already only lightly regulated, will probably get even more of a free pass from the next Trump FDA.
'Medical Freedom' or 'Nanny State'
Trump's health influencers are not monolithic. Analysts see potential clashes among Kennedy, Musk, and more traditional GOP voices. Casey Means, a "holistic" MD at the center of Kennedy's "Make America Healthy Again" team, calls for the government to cut ties with industry and remove sugar, processed food, and toxic substances from American diets. Republicans lampooned such policies as exemplifying a "nanny state" when Mike Bloomberg promoted them as mayor of New York City.
Both the libertarian and "medical freedom" wings oppose aspects of regulation, but Silicon Valley biotech supporters of Trump, like Samuel Hammond of the Foundation for American Innovation, have pressed the agency to speed drug and device approvals, while Kennedy's team says the FDA and other agencies have been "captured" by industry, resulting in dangerous and unnecessary drugs, vaccines, and devices on the market.
Kennedy and Casey Means want to end industry user fees that pay for drug and device rules and support nearly half the FDA's $7.2 billion budget. It's unclear whether Congress would make up the shortfall at a time when Trump and Musk have vowed to slash government programs. User fees are set by laws Congress passes every five years, most recently in 2022.
The industry supports the user-fee system, which bolsters FDA staffing and speeds product approvals. Writing new rules "requires an enormous amount of time, effort, energy, and collaboration" by FDA staff, Troy said. Policy changes made through informal "guidance" alone are not binding, he added.
Kennedy and the Means siblings have suggested overhauling agricultural policies so that they incentivize the cultivation of organic vegetables instead of industrial corn and soy, but "I don't think they'll be very influential in that area," Caplan said. "Big Ag is a powerful entrenched industry, and they aren't interested in changing."
"There's a fine line between the libertarian impulse of the 'medical freedom' types and advocating a reformation of American bodies, which is definitely 'nanny state' territory," said historian Robert Johnston of the University of Illinois-Chicago.
Specific federal agencies are likely to face major changes. Republicans want to trim the NIH's 27 research institutes and centers to 15, slashing Anthony Fauci's legacy by splitting the National Institute of Allergy and Infectious Diseases, which he led for 38 years, into two or three pieces.
Numerous past attempts to slim down the NIH have failed in the face of campaigns by patients, researchers, and doctors. GOP lawmakers have advocated substantial cuts to the CDC budget in recent years, including an end to funding gun violence, climate change, and health equity research. If carried out, Project 2025, a policy blueprint from the conservative Heritage Foundation, would divide the agency into data-collecting and health-promoting arms. The CDC has limited clout in Washington, although former CDC directors and public health officials are defending its value.
"It would be surprising if CDC wasn't on the radar" for potential change, said Anne Schuchat, a former principal deputy director of the agency, who retired in 2021.
The CDC's workforce is "very employable" and might start to look for other work if "their area of focus is going to be either cut or changed," she said.
Kennedy's attacks on HHS and its agencies as corrupted tools of the drug industry, and his demands that the FDA allow access to scientifically controversial drugs, are closely reminiscent of the 1970s campaign by conservative champions of Laetrile, a dangerous and ineffective apricot-pit derivative touted as a cancer treatment. Just as Kennedy championed off-patent drugs like ivermectin and hydroxychloroquine to treat covid, Laetrile's defenders claimed that the FDA and a profit-seeking industry were conspiring to suppress a cheaper alternative.
The public and industry have often been skeptical of health regulatory agencies over the decades, Grossman said. The agencies succeed best when they are called in to fix things — particularly after bad medicine kills or damages children, he said.
The 1902 Biologics Control Act, which created the NIH's forerunner, was enacted in response to smallpox vaccine contamination that killed at least nine children in Camden, New Jersey. Child poisonings linked to the antifreeze solvent for a sulfa drug prompted the modern FDA's creation in 1938. The agency, in 1962, acquired the power to demand evidence of safety and efficacy before the marketing of drugs after the thalidomide disaster, in which children of pregnant women taking the anti-nausea drug were born with terribly malformed limbs.
If vaccination rates plummet and measles and whooping cough outbreaks proliferate, babies could die or suffer brain damage. "It won't be harmless for the administration to broadly attack public health," said Alfredo Morabia, a professor of epidemiology at Columbia University and the editor-in-chief of the American Journal of Public Health. "It would be like taking away your house insurance."
Sam Whitehead, Stephanie Armour, David Hilzenrath, and Darius Tahir contributed to this report.
[Update: This article was updated on the evening of Nov. 14 to reflect Trump's nomination of Kennedy as secretary of the Department of Health and Human Services and movement in some pharmaceutical companies' stock prices.]
In April, just 12 weeks into her pregnancy, Kathleen Clark was standing at the receptionist window of her OB-GYN's office when she was asked to pay $960, the total the office estimated she would owe after she delivered.
Clark, 39, was shocked that she was asked to pay that amount during this second prenatal visit. Normally, patients receive the bill after insurance has paid its part, and for pregnant women that's usually only when the pregnancy ends. It would be months before the office filed the claim with her health insurer.
Clark said she felt stuck. The Cleveland, Tennessee, obstetrics practice was affiliated with a birthing center where she wanted to deliver. Plus, she and her husband had been wanting to have a baby for a long time. And Clark was emotional, because just weeks earlier her mother had died.
"You're standing there at the window, and there's people all around, and you're trying to be really nice," recalled Clark, through tears. "So, I paid it."
On online baby message boards and other social media forums, pregnant women say they are being asked by their providers to pay out-of-pocket fees earlier than expected. The practice is legal, but patient advocacy groups call it unethical. Medical providers argue that asking for payment up front ensures they get compensated for their services.
How frequently this happens is hard to track because it is considered a private transaction between the provider and the patient. Therefore, the payments are not recorded in insurance claims data and are not studied by researchers.
Patients, medical billing experts, and patient advocates say the billing practice causes unexpected anxiety at a time of already heightened stress and financial pressure. Estimates can sometimes be higher than what a patient might ultimately owe and force people to fight for refunds if they miscarry or the amount paid was higher than the final bill.
Up-front payments also create hurdles for women who may want to switch providers if they are unhappy with their care. In some cases, they may cause women to forgo prenatal care altogether, especially in places where few other maternity care options exist.
It's "holding their treatment hostage," said Caitlin Donovan, a senior director at the Patient Advocate Foundation.
Medical billing and women's health experts believe OB-GYN offices adopted the practice to manage the high cost of maternity care and the way it is billed for in the U.S.
When a pregnancy ends, OB-GYNs typically file a single insurance claim for routine prenatal care, labor, delivery, and, often, postpartum care. That practice of bundling all maternity care into one billing code began three decades ago, said Lisa Satterfield, senior director of health and payment policy at the American College of Obstetricians and Gynecologists. But such bundled billing has become outdated, she said.
Previously, pregnant patients had been subject to copayments for each prenatal visit, which might lead them to skip crucial appointments to save money. But the Affordable Care Act now requires all commercial insurers to fully cover certain prenatal services. Plus, it's become more common for pregnant women to switch providers, or have different providers handle prenatal care, labor, and delivery — especially in rural areas where patient transfers are common.
Some providers say prepayments allow them to spread out one-time payments over the course of the pregnancy to ensure that they are compensated for the care they do provide, even if they don't ultimately deliver the baby.
"You have people who, unfortunately, are not getting paid for the work that they do," said Pamela Boatner, who works as a midwife in a Georgia hospital.
While she believes women should receive pregnancy care regardless of their ability to pay, she also understands that some providers want to make sure their bill isn't ignored after the baby is delivered. New parents might be overloaded with hospital bills and the costs of caring for a new child, and they may lack income if a parent isn't working, Boatner said.
In the U.S., having a baby can be expensive. People who obtain health insurance through large employers pay an average of nearly $3,000 out-of-pocket for pregnancy, childbirth, and postpartum care, according to the Peterson-KFF Health System Tracker. In addition, many people are opting for high-deductible health insurance plans, leaving them to shoulder a larger share of the costs. Of the 100 million U.S. people with health care debt, 12% attribute at least some of it to maternity care, according to a 2022 KFF poll.
Families need time to save money for the high costs of pregnancy, childbirth, and child care, especially if they lack paid maternity leave, said Joy Burkhard, CEO of the Policy Center for Maternal Mental Health, a Los Angeles-based policy think tank. Asking them to prepay "is another gut punch," she said. "What if you don't have the money? Do you put it on credit cards and hope your credit card goes through?"
Calculating the final costs of childbirth depends on multiple factors, such as the timing of the pregnancy, plan benefits, and health complications, said Erin Duffy, a health policy researcher at the University of Southern California's Schaeffer Center for Health Policy and Economics. The final bill for the patient is unclear until a health plan decides how much of the claim it will cover, she said.
But sometimes the option to wait for the insurer is taken away.
During Jamie Daw's first pregnancy in 2020, her OB-GYN accepted her refusal to pay in advance because Daw wanted to see the final bill. But in 2023, during her second pregnancy, a private midwifery practice in New York told her that since she had a high-deductible plan, it was mandatory to pay $2,000 spread out with monthly payments.
Daw, a health policy researcher at Columbia University, delivered in September 2023 and got a refund check that November for $640 to cover the difference between the estimate and the final bill.
"I study health insurance," she said. "But, as most of us know, it's so complicated when you're really living it."
While the Affordable Care Act requires insurers to cover some prenatal services, it doesn't prohibit providers from sending their final bill to patients early. It would be a challenge politically and practically for state and federal governments to attempt to regulate the timing of the payment request, said Sabrina Corlette, a co-director of the Center on Health Insurance Reforms at Georgetown University. Medical lobbying groups are powerful and contracts between insurers and medical providers are proprietary.
Because of the legal gray area, Lacy Marshall, an insurance broker at Rapha Health and Life in Texas, advises clients to ask their insurer if they can refuse to prepay their deductible. Some insurance plans prohibit providers in their network from requiring payment up front.
If the insurer says they can refuse to pay up front, Marshall said, she tells clients to get established with a practice before declining to pay, so that the provider can't refuse treatment.
Clark said she met her insurance deductible after paying for genetic testing, extra ultrasounds, and other services out of her health care flexible spending account. Then she called her OB-GYN's office and asked for a refund.
"I got my spine back," said Clark, who had previously worked at a health insurer and a medical office. She got an initial check for about half the $960 she originally paid.
In August, Clark was sent to the hospital after her blood pressure spiked. A high-risk pregnancy specialist — not her original OB-GYN practice — delivered her son, Peter, prematurely via emergency cesarean section at 30 weeks.
It was only after she resolved most of the bills from the delivery that she received the rest of her refund from the other OB-GYN practice.
This final check came in October, just days after Clark brought Peter home from the hospital, and after multiple calls to the office. She said it all added stress to an already stressful period.
"Why am I having to pay the price as a patient?" she said. "I'm just trying to have a baby."
KFF Health News has sued HHS' Office of Inspector General to compel it to release a range of Medicare Advantage health plan audits and other financial records.
The suit, filed Nov. 12 in U.S. District Court in San Francisco under the Freedom of Information Act, or FOIA, seeks documents from the HHS inspector general's office, which acts as a watchdog over federal health insurance programs run by CMS.
The suit asks for correspondence and other records of contact between HHS officials or their representatives and Medicare Advantage organizations concerning overpayment audit findings and potential financial penalties.
It also seeks records reflecting communication between HHS and CMS officials regarding the government's policies for recovering overpayments discovered during Medicare Advantage audits, including a controversial decision in January 2023 to limit dollar recoveries for audits dating back a decade or more.
Additionally, the suit seeks copies of government contracts awarded to outside firms that have conducted Medicare Advantage audits, including budgets and performance evaluations, dating to 2020. In these audits, reviewers take a sample of 200 patients from a health plan and determine whether medical records support the diagnoses the government paid health plans to treat.
KFF Health News requested the records in August, but, more than two months later, "no documents, responsive or otherwise, have been produced," the suit says.
Sam Cate-Gumpert, an attorney with Davis Wright Tremaine, which is representing KFF Health News pro bono in the case, said the information is "critically important to public oversight of government misspending."
According to the suit, the inspector general's office has audited the Medicare Advantage program more than three dozen times since 2019, revealing billions of dollars in overpayments.
But government officials have not recouped the overcharges, according to the suit.
The HHS Office of Inspector General "has left taxpayers footing the bill for billions of dollars in overpayments — even though HHS OIG's primary purpose is to combat fraud and waste in Medicare and other federally funded health programs," the suit alleges.
"In fact, taxpayers have been forced to pay for the Medicare Advantage program's wasteful spending twice — first, because of the program itself, and second, because of the costs of the audits, which the government spends millions of dollars to conduct," according to the suit.
Medicare Advantage, mostly run by private insurance companies, has enrolled more than 33 million seniors and people with disabilities, more than half of people on Medicare.
But the program has faced criticism that it costs billions of dollars more than it should with research showing that many health plans exaggerate how sick patients are to boost payments.
A FOIA lawsuit filed by KFF Health News in September 2019 prompted CMS to release summaries of 90 Medicare Advantage audits revealing millions of dollars in overpayments. As part of a settlement, CMS paid $63,000 in KFF Health News' legal fees, though it did not admit to wrongfully withholding the records.
The HHS Office of Inspector General had no immediate comment on the suit.
A new federal watchdog audit is ratcheting up pressure on government officials to crack down on billions of dollars in overcharges linked to Medicare Advantage home visits.
But so far, the Centers for Medicare & Medicaid Services has rejected a recommendation from the Health and Human Services Inspector General to limit payments stemming from house visits that don't result in any medical treatment — a potential red flag that may signal overcharges.
In late October, the HHS watchdog found that the health plans pocketed $7.5 billion in 2023 from diagnosing health conditions that prompted no medical services — about $4.2 billion of it through health assessments done in patients' homes. And court records show that for a decade or more, CMS officials have failed to act on their concerns that the home visits waste tax dollars and should be limited.
UnitedHealthcare, the largest Medicare Advantage contractor, accounted for about two-thirds of the payments tied to home visits and chart reviews, in which health plans mine patient medical files to add new diagnoses that can bring in additional revenue, according to the audit.
Assistant Inspector General Erin Bliss said the health plans are making billions without offering any treatment for medical conditions they flag during the visits, such as diabetes and major depression.
"Frankly, it needs to stop," Bliss said.
CMS, which runs the Medicare program, disagrees.
In a statement to KFF Health News by spokesperson Alexx Pons, the agency said it "appreciates the OIG's review in this area" and will continue to study the issue.
However, CMS disagreed with the OIG's call to restrict use of home health assessments in computing how much to pay health plans. People on Medicare "should have access to care that is appropriately provided in the home setting," CMS wrote in a written response included in the audit report.
"One would think that CMS would kick its regulatory oversight up a notch or two," said Richard Lieberman, a Colorado health data analytics expert.
"In contrast, CMS appears to be unconcerned and is telling OIG to stay out of their lane," he said.
UnitedHealthcare spokesperson Heather Soule said in a statement that the OIG had drawn "inaccurate conclusions" in the audit.
The home visits are "among the most comprehensive and thorough assessments of a patient's health and physical environment available in the healthcare system, helping to identify and drive needed follow-on care for the vast majority of the patients with whom we engage," according to the company.
No Care Provided
Government spending on Medicare Advantage, which is dominated by UnitedHealthcare and a handful of other health insurance companies, is expected to hit $462 billion this year.
The industry, whose more than 33 million members make up over half of people eligible for Medicare, argues that most enrollees are satisfied with the care they receive and typically pay less out-of-pocket than those on original Medicare.
Whether Medicare Advantage is a good deal for taxpayers is another matter, largely because many health plans exaggerate how sick patients are to boost their payments, multiple federal audits and other investigations have shown. Medicare pays the health plans higher rates for sicker patients.
For fiscal year 2023, CMS identified $12.7 billion in overpayments linked to diagnoses not supported by patients' medical records.
The OIG audit tied $7.5 billion in payments to health conditions that prompted no treatment, including serious diseases such as diabetes, congestive heart failure, and major depression. That suggests that the medical condition either didn't exist or that the health plan failed to treat it adequately, auditors said.
"These are serious conditions. You would think you would see additional care during that year," said Jacqualine Reid, who led the OIG audit team. "We are asking CMS to step up its oversight."
Homegrown
The in-home visits have sparked controversy for more than a decade. A June 2014 media investigation found that a sharp rise in home visits had inflated Medicare's costs by billions of dollars. The visits, which typically last less than an hour, are often conducted by nurse practitioners, who do not treat the patient, but go over a checklist of possible health conditions.
Sabrina Skeldon, a Texas lawyer who advises physicians on billing issues, said problems arise when health plans fail to order necessary medical tests to confirm a diagnosis made during a home visit — and treat it.
Skeldon noted that The Cigna Group in 2023 paid $172 million to settle a whistleblower lawsuit that alleged its Medicare Advantage plan illegally collected payments for medical diagnoses that were based solely on in-home assessments.
The OIG audit comes as the Justice Department presses a civil fraud case that accuses UnitedHealth Group of cheating Medicare out of more than $2 billion by mining patient records to churn up diagnoses that boosted revenue, while ignoring evidence of overpayments. The company denies the allegations.
Court filings from the case show CMS officials were concerned years ago that home visits and chart reviews could needlessly drive up costs.
In April 2014, CMS backed off a proposal to restrict their use amid complaints from the industry that it would lose billions of dollars as a result. Similarly, CMS officials scrapped a proposal to tighten scrutiny on the chart reviews after what one official called an "uproar" from the industry.
CMS officials also had concerns that unchecked home visits might affect efforts to recover overpayments through billing reviews known as "RADV" audits.
Former CMS official Thomas Hutchinson, who ran the agency's Medicare Plan Payment Group from September 2006 through June 2010, testified in a deposition that officials had "heard about various folks that figured out how they could RADV-proof things by doing in-home visits."
In a confidential April 2015 slide presentation, CMS officials observed that health plans were "now conducting health risk assessments in beneficiaries' homes. One purpose of the assessments is to identify conditions and create medical records documentation that substantiates diagnoses."
And an October 2015 CMS memo circulated among senior agency staff cites "limitations around home visits" among the possible ways to "strengthen" the RADV audits.
In its statement to KFF Health News, CMS said it was "committed" to ensuring that diagnoses health plans submitted for payment were accurate. But the agency declined to answer written questions about the impact of home visits on its audit program, which has yet to complete reviews of payments dating back as far as 2011.
UnitedHealthcare had the lowest rates of unconfirmed diagnoses among five large Medicare Advantage organizations audited in 2011, according to court records.
Overall, the company ended up with underpayments of more than $261 million for 15 of its plans audited for 2011-2013, court records show. The audit findings for other Medicare Advantage firms are blacked out in court filings.
CMS audits payments to just 30 out of more than 700 contracts a year. That's not enough to protect tax dollars, said Matthew Fiedler, a health policy researcher at The Brookings Institution.
"They should be auditing 10 times as many contracts," he said. "Where we are now you are not likely to get caught."
HURON, S.D. — Kelly Engebretson was excited to get fitted for a prosthetic after having part of his leg amputated. But he wasn't sure how he'd get to the appointment.
Nah Thu Thu Win's twin sons needed vaccinations before starting kindergarten. But she speaks little English, and the boys lacked health insurance.
William Arce and Wanda Serrano were recovering from recent surgeries. But the couple needed help sorting out their insurance and understanding their bills.
Engebretson, Win, Arce, and Serrano were fortunate to have someone to help.
They're all paired with community health workers in Huron, a city of 14,000 people known for being home to the state fair and what's billed as the world's largest pheasant sculpture.
Three workers, employed by the Huron Regional Medical Center, help patients navigate the health system and address barriers, like poverty or unstable housing, that could keep them from getting care. Community health workers can also provide basic education on managing chronic health problems, such as diabetes or high cholesterol.
Community health worker programs are spreading across the U.S., including in rural areas and small cities as health providers and state and federal governments increasingly invest in them. These initiatives gained attention during the coronavirus pandemic and have been found to improve people's health and access to preventive care while reducing expensive hospital visits.
Community health worker programs can address common barriers in rural areas, where people face higher rates of poverty and certain health problems, said Gabriela Boscán Fauquier, who oversees community health worker initiatives at the National Rural Health Association.
The workers are "an extension of the health care system" and serve as a link "between the formality of this health care system and the community," she said.
The programs are often based at hospital systems or community health centers. The workers have a median pay of $23 an hour, according to the federal Bureau of Labor Statistics. Patients are typically referred to programs by clinicians who notice personal struggles or frequent visits to hospital emergency departments.
South Dakota is among the states that have recently funded community health worker programs, developed training requirements for the workers, and approved Medicaid reimbursement for their services. The state's certification program requires 200 hours of coursework and 40 hours of job shadowing.
Huron Regional Medical Center launched its initiative in fall 2022, after receiving a $228,000 federal grant. The program is now funded by the nonprofit hospital and Medicaid reimbursements.
Huron, a small city surrounded by rural areas, is mostly populated by white people. But thousands of Karen people — an ethnic minority from the Southeast Asian country of Myanmar — began arriving in 2006. Many are refugees. The city also has a significant Hispanic population from the Caribbean, Mexico, and Central and South America.
Mickie Scheibe, one of Huron's community health workers, recently stopped by the house of client Kelly Engebretson. The 61-year-old hadn't been able to work since he had part of his leg amputated, due to diabetes complications.
Scheibe helps with "the hoops you've got to jump through," such as applying for Medicaid, Engebretson said.
He told Scheibe that he didn't know how he was going to get to his prosthetic fitting in Sioux Falls — a two-hour drive from home. Scheibe, 54, said she would help find him a safe ride.
She also invited Engebretson to a diabetes education program.
"Put me down as a definitely absolutely," he replied, adding that he'd invite his mother to tag along.
The same day, Scheibe's co-worker Sau-Mei Ramos visited the apartment where William Arce and Wanda Serrano live. Arce was recovering from heart surgery, while Serrano was healing from knee and shoulder operations.
The couple, both 61, moved three years ago from Puerto Rico to be near their children in Huron. Ramos, who's also from Puerto Rico, coordinated their appointments, answered their billing questions, and helped Arce find a walker and supplemental insurance.
Ramos, 29, handed Arce a pamphlet about heart health and asked him to read the section on angina, the pain that results when not enough blood flows to the heart.
"Qué entiende?" she said, asking Arce what he understood about his condition. Arce, speaking in Spanish, responded that he knew what angina was and what symptoms to watch for.
Later that day, Paw Wah Sa, the third community health worker in town, met with client Nah Thu Thu Win, who moved to Huron in February from Myanmar with her husband and twin 6-year-olds. The Win family, like Sa, are part of the local Karen community, whose people have been persecuted under the military rulers of Myanmar, the country formerly known as Burma.
Win, 29, had assumed the kids would qualify for Medicaid. But unlike most other states, South Dakota does not immediately offer coverage to children who legally immigrated into the U.S. The boys' father hopes to eventually add them to his work-sponsored insurance.
Sa didn't want the kids to have to wait for health care. The 24-year-old previously took the twins to a free mobile dental clinic in Huron. It turned out they needed more advanced dental work, which they could get free only in Sioux Falls. Sa helped make the arrangements.
Many Karen residents and people from rural parts of Latin America had little access to health care before moving to the U.S., Sa and Ramos said. They said a major part of their job is explaining what kind of care is available, and when it's important to seek help.
The three community health workers sometimes take clients grocery shopping, to teach them how to understand labels and identify healthful food.
Boscán Fauquier, with the National Rural Health Association, said that because community health workers are familiar with the cultures they serve, they can suggest affordable food that clients are familiar with.
Rural America's overall population is shrinking, but the 2020 census showed it has become more diverse as people representing ethnic minorities are drawn to jobs in industries such as farming, meatpacking, and mining. Others are attracted by rural areas' lower crime rates and cheaper housing.
Boscán Fauquier said many rural community health worker programs serve people from minority groups, who are more likely than white people to face barriers to health care.
She pointed to programs serving Native American reservations, the Black Belt region of the South, and Spanish-speaking communities, where the workers are called promotoras. But community health workers also serve rural white communities, such as those in Appalachia impacted by the opioid crisis.
Medicare, the federal health program for adults 65 or older, has been reimbursing community health worker services since January. Boscán Fauquier said advocates hope more state Medicaid programs and private insurers will allow reimbursement too.
Engebretson said he's happy to see community health workers across South Dakota, not just in big cities.
The more they "can branch out to the people, the better it would be," he said.
Vermonters pay the highest prices nationwide for individual health coverage, and state reports show its providers and insurers are in financial trouble.
This article was published on Wednesday, November 6, 2024 in KFF Health News.
RICHMOND, Vt. — On a warm autumn morning, Roger Brown walked through a grove of towering trees whose sap fuels his maple syrup business. He was checking for damage after recent flooding. But these days, his workers' health worries him more than his trees'.
The cost of Slopeside Syrup's employee health insurance premiums spiked 24% this year. Next year it will rise 14%.
The jumps mean less money to pay workers, and expensive insurance coverage that doesn't ensure employees can get care, Brown said. "Vermont is seen as the most progressive state, so how is healthcare here so screwed up?"
Vermont consistently ranks among the healthiest states, and its unemployment and uninsured rates are among the lowest. Yet Vermonters pay the highest prices nationwide for individual health coverage, and state reports show its providers and insurers are in financial trouble. Nine of the state's 14 hospitals are losing money, and the state's largest insurer is struggling to remain solvent. Long waits for care have become increasingly common, according to state reports and interviews with residents and industry officials.
Rising health costs are a problem across the country, but Vermont's situation surprises health experts because virtually all its residents have insurance and the state regulates care and coverage prices.
For more than 15 years, federal and state policymakers have focused on increasing the number of people insured, which they expected would shore up hospital finances and make care more available and affordable.
"Vermont's struggles are a wake-up call that insurance is only one piece of the puzzle to ensuring access to care," said Keith Mueller, a rural health expert at the University of Iowa.
Regulators and consultants say the state's small, aging population of about 650,000 makes spreading insurance risk difficult. That demographic challenge is compounded by geography, as many Vermonters live in rural areas, where it's difficult to attract more health workers to address shortages.
At least part of the cost spike can be attributed to patients crossing state lines for quicker care in New York and Massachusetts. Those visits can be more expensive for both insurers and patients because of long ambulance rides and charges from out-of-network providers.
Patients who stay, like Lynne Drevik, face long waits. Drevik said her doctor told her in April that she needed knee replacement surgeries — but the earliest appointment would be in January for one knee and the following April for the other.
Drevik, 59, said it hurts to climb the stairs in the 19th-century farmhouse in Montgomery Center she and her husband operate as an inn and a spa. "My life is on hold here, and it's hard to make any plans," she said. "It's terrible."
Health experts say some of the state's health system troubles are self-inflicted.
Unlike most states, Vermont regulates hospital and insurance prices through an independent agency, the Green Mountain Care Board. Until recently, the board typically approved whatever price changes companies wanted, said Julie Wasserman, a health consultant in Vermont.
The board allowed one health system — the University of Vermont Health Network — to control about two-thirds of the state's hospital market and allowed its main facility, the University of Vermont Medical Center in Burlington, to raise its prices until it ranked among the nation's most expensive, she said, citing data the board presented in September.
Hospital officials contend their prices are no higher than industry averages.
But for 2025, the board required the University of Vermont Medical Center to cut the prices it bills private insurers by 1%.
The nonprofit system says it is navigating its own challenges. Top officials say a severe lack of housing makes it hard to recruit workers, while too few mental health providers, nursing homes, and long-term care services often create delays in discharging patients, adding to costs.
Two-thirds of the system's patients are covered by Medicare or Medicaid, said CEO Sunny Eappen. Both government programs pay providers lower rates than private insurance, which Eappen said makes it difficult to afford rising prices for drugs, medical devices, and labor.
Officials at the University of Vermont Medical Center point to several ways they are trying to adapt. They cited, for example, $9 million the hospital system has contributed to the construction of two large apartment buildings to house new workers, at a subsidized price for lower-income employees.
The hospital also has worked with community partners to open a mental health urgent care center, providing an alternative to the emergency room.
In the ER, curtains separate areas in the hallway where patients can lie on beds or gurneys for hours waiting for a room. The hospital also uses what was a storage closet as an overflow room to provide care.
"It's good to get patients into a hallway, as it's better than a chair," said Mariah McNamara, an ER doctor and associate chief medical officer with the hospital.
For the about 250 days a year when the hospital is full, doctors face pressure to discharge patients without the ideal home or community care setup, she said. "We have to go in the direction of letting you go home without patient services and giving that a try, because otherwise the hospital is going to be full of people, and that includes people that don't need to be here," McNamara said.
Searching for solutions, the Green Mountain Care Board hired a consultant who recommended a number of changes, including converting four rural hospitals into outpatient facilities, in a worst-case scenario, and consolidating specialty services at several others.
The consultant, Bruce Hamory, said in a call with reporters that his report provides a road map for Vermont, where "the healthcare system is no match for demographic, workforce, and housing challenges."
But he cautioned that any fix would require sacrifice from everyone, including patients, employers, and health providers. "There is no simple single policy solution," he said.
One place Hamory recommended converting to an outpatient center only was North Country Hospital in Newport, a village in Vermont's least populated region, known as the Northeast Kingdom.
The 25-bed hospital has lost money for years, partly because of an electronic health record system that has made it difficult to bill patients. But the hospital also has struggled to attract providers and make enough money to pay them.
Officials said they would fight any plans to close the hospital, which recently dropped several specialty services, including pulmonology, neurology, urology, and orthopedics. It doesn't have the cash to upgrade patient rooms to include bathroom doors wide enough for wheelchairs.
On a recent morning, CEO Tom Frank walked the halls of his hospital. The facility was quiet, with just 14 admitted patients and only a couple of people in the ER. "This place used to be bustling," he said of the former pulmonology clinic.
Frank said the hospital breaks even treating Medicare patients, loses money treating Medicaid patients, and makes money from a dwindling number of privately insured patients.
The state's strict regulations have earned it an antihousing, antibusiness reputation, he said. "The cost of healthcare is a symptom of a larger problem."
About 30 miles south of Newport, Andy Kehler often worries about the cost of providing health insurance to the 85 workers at Jasper Hill Farm, the cheesemaking business he co-owns.
"It's an issue every year for us, and it looks like there is no end in sight," he said.
Jasper Hill pays half the cost of its workers' health insurance premiums because that's all it can afford, Kehler said. Employees pay $1,700 a month for a family, with a $5,000 deductible.
"The coverage we provide is inadequate for what you pay," he said.
Former President Donald Trump's election victory and looming return to the White House will likely bring changes that scale back the nation's public health insurance programs — increasing the uninsured rate, while imposing new barriers to abortion and other reproductive care.
The reverberations will be felt far beyond Washington, D.C., and could include an erosion of the Affordable Care Act's consumer protections, the imposition of work requirements in Medicaid and funding cuts to the safety net insurance, and challenges to federal agencies that safeguard public health. Abortion restrictions may tighten nationwide with a possible effort to restrict the mailing of abortion medications.
And with the elevation of vaccine skeptic Robert F. Kennedy Jr. to Trump's inner circle of advisers, public health interventions with rigorous scientific backing — whether fluoridating public water supplies or inoculating children — could come under fire.
Trump defeated Vice President Kamala Harris with 277 Electoral College votes, The Associated Press declared at 5:34 a.m. ET on Wednesday. He won 51% of the vote nationally to Harris' 47.5%, the AP projected.
Trump's victory will give a far broader platform to skeptics and critics of federal health programs and actions. Worst case, public health authorities worry, the U.S. could see increases in preventable illnesses; a weakening of public confidence in established science; and debunked notions — such as a link between vaccines and autism — adopted as policy. Trump said in an NBC News interview on Nov. 3 that he would "make a decision" about banning some vaccines, saying he would consult with Kennedy and calling him "a very talented guy."
While Trump has said he will not try again to repeal the Affordable Care Act, his administration will face an immediate decision next year on whether to back an extension of enhanced premium subsidies for Obamacare insurance plans. Without the enhanced subsidies, steep premium increases causing lower enrollment are projected. The current uninsured rate, about 8%, would almost certainly rise.
Policy specifics have not moved far beyond the "concepts of a plan" Trump said he had during his debate with Harris, though Vice President-elect JD Vance later said the administration would seek to inject more competition into ACA marketplaces.
Republicans were projected to claim a Senate majority, in addition to the White House, while control of the House was not yet resolved early Wednesday.
Polls show the ACA has gained support among the public, including provisions such as preexisting condition protections and allowing young people to stay on family health plans until they are 26.
Trump supporters and others who have worked in his administration say the former president wants to improve the law in ways that will lower costs. They say he has already shown he will be forceful when it comes to lowering high healthcare prices, pointing to efforts during his presidency to pioneer price transparency in medical costs.
"On affordability, I'd see him building on the first term," said Brian Blase, who served as a Trump health adviser from 2017 to 2019. Relative to a Democratic administration, he said, there will be "much more focus" on "minimizing fraud and waste."
Efforts to weaken the ACA could include slashing funds for enrollment outreach, enabling consumers to purchase more health plans that don't comply with ACA consumer protections, and allowing insurers to charge sicker people higher premiums.
Democrats say they expect the worst.
"We know what their agenda is," said Leslie Dach, executive chair of Protect Our Care, a healthcare policy and advocacy organization in Washington, D.C. He worked in the Obama administration helping to implement the ACA. "They're going to raise costs for millions of Americans and rip coverage away from millions and, meanwhile, they will give tax breaks to rich people."
Theo Merkel, director of the Private Health Reform Initiative at the right-leaning Paragon Health Institute, which Blase leads, said the enhanced ACA subsidies extended by the Inflation Reduction Act in 2022 do nothing to improve plans or lower premiums. He said they paper over the plans' low value with larger government subsidies.
Other Trump supporters say the president-elect may support preserving Medicare's authority to negotiate drug prices, another provision of the IRA. Trump has championed reducing drug prices, and in 2020 advanced a test model that would have tied the prices of some drugs in Medicare to lower costs overseas, said Merkel, who worked in Trump's first White House. The drug industry successfully sued to block the program.
Within Trump's circles, some names have already been floated as possible leaders for the Department of Health and Human Services. They include former Louisiana Gov. Bobby Jindal and Seema Verma, who ran the Centers for Medicare & Medicaid Services during the Trump administration.
Kennedy, who suspended his independent presidential run and endorsed Trump, has told his supporters that Trump promised him control of HHS. Trump said publicly before Election Day that he would give Kennedy a big role in his administration, but he may have difficulty winning Senate confirmation for a Cabinet position.
While Trump has vowed to protect Medicare and said he supports funding home care benefits, he's been less specific about his intentions for Medicaid, which provides coverage to lower-income and disabled people. Some health analysts expect the program will be especially vulnerable to spending cuts, which could help finance the extension of tax breaks that expire at the end of next year.
Possible changes include the imposition of work requirements on beneficiaries in some states. The administration and Republicans in Congress could also try to revamp the way Medicaid is funded. Now, the federal government pays states a variable percentage of program costs. Conservatives have long sought to cap the federal allotments to states, which critics say would lead to draconian cuts.
"Medicaid will be a big target in a Trump administration," said Larry Levitt, executive vice president for health policy at KFF, a health information nonprofit that includes KFF Health News.
Less clear is the potential future of reproductive health rights.
Trump has said decisions about abortion restrictions should be left to the states. Thirteen states ban abortion with few exceptions, while 28 others restrict the procedure based on gestational duration, according to the Guttmacher Institute, a research and policy organization focused on advancing reproductive rights. Trump said before the election that he would not sign a national abortion ban.
State ballot measures to protect abortion rights were adopted in four states, including Missouri, which Trump won by about 18 points, according to preliminary AP reports. Abortion rights measures were rejected by voters in Florida and South Dakota.
Trump could move to restrict access to abortion medications, used in more than half of abortions, either by withdrawing the FDA's authorization for the drugs or by enforcing a 19th-century law, the Comstock Act, that abortion opponents say bans their shipment. Trump has said he generally would not use the law to ban mail delivery of the drugs.
KINGSTREE, S.C. — One morning in late April, a small brick health clinic along the Thurgood Marshall Highway bustled with patients.
There was Joshua McCray, 69, a public bus driver who, four years after catching COVID-19, still is too weak to drive.
Louvenia McKinney, 77, arrived complaining about shortness of breath.
Ponzella McClary brought her 83-year-old mother-in-law, Lula, who has memory issues and had recently taken a fall.
Morris Brown, the family practice physician who owns the clinic, rotated through Black patients nearly every 20 minutes. Some struggled to walk. Others pulled oxygen tanks. And most carried three pill bottles or more for various chronic ailments.
But Brown called them "lucky," with enough health insurance or money to see a doctor. The clinic serves patients along the infamous "Corridor of Shame," a rural stretch of South Carolina with some of the worst health outcomes in the nation.
"There is a lot of hopelessness here," Brown said. "I was trained to keep people healthy, but like 80% of the people don't come see the doctor, because they can't afford it. They're just dying off."
About 50 miles from the sandy beaches and golf courses along the coastline of this racially divided state, Morris' independent practice serves the predominantly Black town of roughly 3,200 people. The area has stark health care provider shortages and high rates of chronic disease, such as diabetes, high blood pressure, and heart disease.
Such racial inequities are especially severe across the Southeast, home to most of the country's Black population.
But South Carolina remains one of the few states where lawmakers refuse to expand Medicaid, despite research that shows it would provide medical insurance to hundreds of thousands of people and create thousands of health care jobs across the state.
The decision means there will be more preventable deaths in the 17 poverty-stricken counties along Interstate 95 that comprise the Corridor of Shame, Brown said.
"There is a disconnect between policymakers and real people," he said. The African Americans who make up most of the town's population "are not the people in power."
The U.S. health care system, "by its very design, delivers different outcomes for different populations," said a June report from the National Academies of Sciences, Engineering, and Medicine. Those racial and ethnic inequities "also contribute to millions of premature deaths, resulting in loss of years of life and economic productivity."
Over a recent two-decade span, mounting research shows, the United States has made almost no progress in eliminating racial disparities in key health indicators, even as political and public health leaders vowed to do so.
And that's not an accident, according to academic researchers, doctors, politicians, community leaders, and dozens of other people KFF Health News interviewed.
Federal, state, and local governments, they said, have put systems in place that maintain the status quo and leave the well-being of Black people at the mercy of powerful business and political interests.
Legacy of racism
Across the nation, authorities have permitted nearly 80% of all municipal solid waste incinerators — linked to lung cancer, high blood pressure, higher risk of miscarriages and stillbirths, and non-Hodgkin lymphoma — to be built in Black, Latinx, and low-income communities, according to a complaint filed with the federal government against the state of Florida.
Federal lawmakers slowed investing in public housing as people of color moved in, leaving homes with mold, vermin, and other health hazards.
And Louisiana and other states passed laws allowing the carrying of concealed firearms without a permit even though gun violence is now the No. 1 killer of kids and teens. Research shows Black youth ages 1 to 17 are 18 times more likely to suffer a gun homicide than their white counterparts.
"People are literally dying because of policy decisions in the South," said Bakari Sellers, a Democratic former state representative in South Carolina.
KFF Health News undertook a yearlong examination of how government decisions undermine Black health — reviewing court and inspection records and government reports, and interviewing dozens of academic researchers, doctors, politicians, community leaders, grieving moms, and patients.
From the cradle to the grave, Black Americans suffer worse health outcomes than white people. They endure greater exposure to toxic industrial pollution, dangerously dilapidated housing, gun violence, and other social conditions linked to higher incidence of cancer, asthma, chronic stress, maternal and infant mortality, and myriad other health problems. They die at younger ages, and COVID shortened lives even more.
Disparities in American health care mean Black people have less access to quality medical care, researchers say. They are less likely to have health insurance and, when they seek medical attention, they report widespread incidents of discrimination by health care providers, a KFF survey shows. Even tools meant to help detect health problems may systematically fail people of color.
All signs pointed to systems rooted in the nation's painful racist history, which even today affects all facets of American life.
"So much of what we see is the long tail of slavery and Jim Crow," said Andrea Ducas, vice president of health policy at the Center for American Progress, a nonprofit think tank.
Put simply, said Jameta Nicole Barlow, a community health psychologist and professor at George Washington University, government actions send a clear message to Black people: "Who are you to ask for health care?"
The end of slavery gave way to laws that denied Black people in the U.S. basic rights, enforced racial segregation, and subjected them to horrific violence.
"I can take facts from 100 years ago about segregation and lynchings for a county and I can predict the poverty rate and life expectancy with extraordinary precision," said Luke Shaefer, a professor of social justice and public policy at the University of Michigan.
Starting in the 1930s, the federal government sorted neighborhoods in 239 cities and deemed redlined areas — typically home to Black people, Jews, immigrants, and poor white people — unfit for mortgage lending. That process concentrated Black people in neighborhoods prone to discrimination.
Local governments steered power plants, oil refineries, and other industrial facilities to Black neighborhoods, even as research linked them to increased risks of cardiovascular and respiratory diseases, cancer, and preterm births.
An ineffective government response
The federal government did not even begin to track racial disparities in health care until the 1980s, and at that time disparities in heart disease, infant mortality, cancer, and other major categories accounted for about 60,000 excess deaths among Black people each year. Elevated rates of six diseases, including cancer, addiction, and diabetes, accounted for more than 80% of the excess mortality for Black and other minority populations, according to "The Heckler Report," released in 1985. During the past two decades there have been 1.63 million excess deaths among Black Americans relative to white Americans. That represents a loss of more than 80 million years of life, according to a 2023 JAMA study.
Recent efforts to address health disparities have run headlong into racist policies still entrenched in health systems. The design of the U.S. health care system and structural barriers have led to persistent health inequities that cost more than a million lives and billions of dollars, according to the National Academies report.
"When COVID was first hitting, it was just sort of immediately clear who was going to suffer the most," Ducas said, "not just because of differential access to care, but who was in a living environment that's multigenerational or crowded, who is more likely to be in a job where they are an essential worker, who is going to be more reliant on public transportation."
For example, in spring 2020, the North Carolina health department, led by current Centers for Disease Control and Prevention director Mandy Cohen, failed to get COVID testing to vulnerable Black communities where people were getting sick and dying from COVID-related causes at far higher rates than white people.
And Black Americans were far more likely to hold jobs — in areas such as transportation, health care, law enforcement, and food preparation — that the government deemed essential to the economy and functioning of society, making them more susceptible to COVID, according to research.
Until Joshua McCray, the bus driver in Kingstree, S.C., got COVID in his mid-60s, he was strong enough to hold two jobs. He ended up on a feeding tube and a ventilator after he contracted COVID in 2020 while taking other essential workers from this predominantly Black area to jobs in a whiter, wealthier tourist town.
Now he cannot work and at times has difficulty walking.
"I can tell you the truth now: It was only the Good Lord that saved him," said Brown, the rural physician who treated McCray and many patients like him.
Federal and state governments have spent billions of dollars to implement the Affordable Care Act, the Children's Health Insurance Program, and other measures to increase access to health care. Yet, experts said, many of the problems identified in "The Heckler Report" persist.
When Lakeisha Preston in Mississippi was diagnosed with walking pneumonia in 2019, she ended up with a $4,500 medical bill she couldn't pay. Preston works at Maximus, which has a $6.6 billion contract with the federal government to help people sign up for Medicare and Affordable Care Act health plans.
She is convinced that being a Black woman made her challenges more likely.
"Think about how many centuries the same thing has been happening," said Preston, noting how her mother worked two jobs her entire life without a vacation and suffered from health conditions including diabetes, cataracts, and carpal tunnel syndrome. Today Preston can't afford to put her 8-year-old son on her health plan, so he's covered by Medicaid.
In email exchanges with the Biden administration, spokespeople insisted that it is making progress in closing the racial health gap. They said officials have taken steps to address food insecurity, housing instability, pollution, and other social determinants of health that help fuel disparities.
President Joe Biden issued an executive order on his first full day in office in 2021 that said "the COVID-19 pandemic has exposed and exacerbated severe and pervasive health and social inequities in America." Later that year, the White House issued another executive order focused on improving racial equity and acknowledged that long-standing racial disparities in health care and other areas have been "at times facilitated by the federal government."
"The Biden-Harris Administration is laser focused on addressing the health needs of Black Americans by dismantling persistent structural inequities," said Renata Miller, a spokesperson for the administration.
The CDC, along with some state and local governments, declared racism a serious public health threat.
U.S. Rep. Alma Adams, a North Carolina Democrat, pushed for "Momnibus" legislation to reduce maternal mortality. Yet federal lawmakers left money for Black maternal health out of the historic Inflation Reduction Act in 2022.
"I come to this space as an elected official, knowing what it is like to be poor, knowing what it is like to not have insurance and having to get up at 3, 4 in the morning with my mom to take my sister to the emergency room," Adams said.
In the 1960s in North Carolina, Adams and her family would take her sister Linda, who had sickle cell anemia, to the emergency room because they had no doctor and could not afford health insurance. Linda died at the age of 26 in 1971.
"You have to have some sensitivity for this work," Adams said. "And a lot of folks that I've worked with don't have it."
'Like having two strikes against you'
The website for Kingstree depicts idyllic images of small-town life, with white people sitting on a porch swing, kayaking on a river, eating ice cream, and strolling with their dogs. Two children wearing masks are the only Black people in the video, even though Black people make up 70% of the town's population.
But life in Kingstree and surrounding communities is marked by poverty, a lack of access to health care, and other socioeconomic disadvantages that have given South Carolina poor rankings in key health indicators such as rates of death and obesity among children and teens.
Some 23% of residents in Williamsburg County, which contains Kingstree, live below the poverty line, about twice the national average, according to federal data.
There is one primary care physician for every 5,080 residents in Williamsburg County. That's far less than in more urbanized and wealthier counties in the state such as Richland, Greenville, and Beaufort.
Edward Simmer, the state's interim public health director, said that if "you are African American in a rural zone, it is like having two strikes against you."
Asked if South Carolina should expand Medicaid, Simmer said the challenges South Carolina and other states confront are worsened by health care provider shortages and structural inequities too large and complicated for Medicaid expansion alone to solve.
"It is not a panacea," he said.
But for Brown and others, the reason South Carolina remains one of the few states that have not expanded Medicaid — one step that could help narrow disparities with little cost to the state — is clear.
"Every year we look at the data, we see the health disparities and we don't have a plan to improve," Brown said. "It has become institutionalized. I call it institutional racism."
A July report from George Washington University found that Medicaid expansion would provide insurance to 360,000 people and add 18,000 jobs in the health care sector in South Carolina.
"Racism is the reason we don't have Medicaid expansion. Full stop," said Janice Probst, a former director of the Rural and Minority Health Research Center in South Carolina. "These are not accidents. There is an idea that you can stay in power by using racism."
South Carolina's Republican governor, Henry McMaster, in July vetoed legislation that would have created a committee to consider Medicaid expansion, saying he did not believe it would be "fiscally responsible."
Expanding Medicaid in the state could result in $4 billion in additional economic output from an influx of federal funds in 2026, according to the July report.
Beyond health care coverage and provider shortages, Black people "have never been given the conditions needed to thrive," said Barlow, the George Washington University professor. "And this is because of white supremacy."
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF.
CUTHBERT, Ga. — While customers at Adams Family Pharmacy picked up their prescriptions on a hot summer day, some stopped in for coffee, ice cream, homemade cake, or cookies.
It wasn't a bake sale, but the sweets bring extra revenue as pharmacist and co-owner Nikki Bryant works to achieve profitability at her business on the town square.
Bryant said she is doing all she can to bolster it against a powerful force that threatens her and other independent pharmacists: the middlemen who manage virtually all prescriptions written in the U.S., called pharmacy benefit managers, or PBMs. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities have drawn scrutiny from Congress, the Federal Trade Commission, and state legislatures for their role in the increase in drug prices.
Bryant and other independent pharmacists say PBMs not only create higher costs but also make it harder for patients to access medications. So they were hopeful about state legislation this year that would have increased their reimbursement to match the average prices paid to retail chain pharmacies through the state employee health plan. But Gov. Brian Kemp vetoed the bill.
Kemp cited a fiscal estimate that it would cost the state as much as $45 million a year and said "the General Assembly failed to fund this initiative."
Underlining the Georgia legislative reform effort against pharmacy benefit managers was an analysis by the American Pharmacy Cooperative, which represents independent pharmacies, that reviewed the price differential paid to a north Georgia pharmacy and nearby chain stores.
The analysis early this year showed chains were paid well beyond the family business for many of the same medications: For example, the chains received an average of nearly $54 for the antidepressant bupropion, while Bell's Family Pharmacy in Tate, Georgia, got $5.54, the analysis said. For a drug used to treat blood pressure, amlodipine, chain pharmacies received an average of $23.55, while Bell's got $1.51.
Bell's Family Pharmacy closed earlier this year.
"The differences in Georgia are unbelievable," Antonio Ciaccia, who runs Ohio-based consulting firm 3 Axis Advisors. "If you're a pharmacist, you don't have any control over which drugs you dispense and which you don't."
By controlling prices and availability, pharmacy benefit managers cause patients and employers to spend more for medications, according to the Federal Trade Commission and pharmacy groups. On Sept. 20, the FTC sued three of the largest PBMs — CVS Health's Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum Rx, which together control about 80% of U.S. prescription drug sales. The agency said they created a "perverse drug rebate system" that artificially inflates the price of insulin. Each company denied the allegations.
The lawsuit followed a scathing FTC report in July that said the "dominant PBMs can often exercise significant control over which drugs are available, at what price, and which pharmacies patients can use to access their prescribed medications."
The trade group that represents PBMs, the Pharmaceutical Care Management Association, said the insulin market is working well and blamed drugmakers for historically higher prices of the medication.
Bryant and other independent pharmacists, though, say they lose money filling certain prescriptions while reimbursements favor chain pharmacies like CVS that have corporate ties to pharmacy benefit managers. And even the chain pharmacies have retrenched, with CVS, Rite Aid, and Walgreens announcing layoffs or store closures in recent months.
"PBMs are like the mafia," Bryant said. "They pay us what they want to pay us. They are sucking all the money out of health care."
Pharmacy benefit managers will charge some health insurance plans more for a medication than what they reimburse a pharmacy, keeping the extra money as profit, critics say. This practice is known as "spread pricing." Large PBMs also take money from drugmakers as a "rebate" to give their drugs preferential treatment on health plans' lists of medications, independent pharmacies say. And by favoring certain pharmacies with whom they have business ties, experts say, these drug brokers help force independent stores such as Bell's to close.
The veto by Kemp, a Republican, came despite the GOP-led General Assembly voting overwhelmingly for Senate Bill 198 on the last day of the legislative session.
Kemp spokesperson Garrison Douglas said, "The governor remains entirely and wholeheartedly supportive of Georgia's independent pharmacists and the need for PBM transparency."
In his veto message, Kemp voiced support for a study of independent pharmacy drug reimbursements and PBM practices. And he said independent pharmacists are getting an extra $3 dispensing fee this year on state employee prescriptions.
The state Department of Community Health, which oversees the State Health Benefit Plan, told KFF Health News that CVS Caremark, the PBM handling the state employee business, supplied the cost estimate Kemp used to justify his veto.
Fiona Roberts, a spokesperson for Community Health, said the department didn't have time to conduct its own analysis.
CVS Caremark said it used historical claims data to calculate the cost impact of the higher reimbursement.
Nationally, criticism of PBM practices intensified over the summer with the Federal Trade Commission report.
The Pharmaceutical Care Management Association pushed back, saying the report "is based on anecdotes and comments from anonymous sources and self-interested parties and supported only by two cherry-picked case studies that are implied to be representative of the entire market."
Members of both parties in Congress have tackled PBM reform. House members recently introduced another proposal, known as the Pharmacists Fight Back Act, which supporters say would add transparency, limit costs for patients, ensure they get the benefit of drugmaker discounts, and protect their pharmacy choices.
The consolidation that has combined health insurers with PBMs — including their operating their own retail, mail-order, and specialty pharmacies — has created financial behemoths, said U.S. Rep. Buddy Carter, a Georgia Republican and a pharmacist. "I'm interested in busting them up," he said.
Alexander Oshmyansky, co-founder of Mark Cuban Cost Plus Drug Company, said the PBMs siphon off about a third of the $400 billion a year spent on pharmaceuticals.
"What we could do as a society with $100 billion as opposed to paying some companies to process drug payments," Oshmyansky said.
PCMA, the trade group, cited a report funded by the three biggest pharmacy benefit managers that said their operating margins are less than 5%.
And the group says that discussions about congressional reform "reflect a one-sided view informed directly by the pharmaceutical industry's blame game designed to vilify PBMs to keep prescription drug prices high and increase drug company profits."
Underpayments by PBMs, however, have accelerated the closures of mom-and-pop pharmacies across the country, said the National Community Pharmacists Association, which represents independent pharmacies.
The U.S. loses almost one such pharmacy a day, said Anne Cassity, a senior vice president of the association. Rural pharmacies, which are hard to reach for patients lacking transportation, are especially vulnerable, she said.
Bryant's two pharmacies deliver to several counties, including to patients who have a disability or no transportation. The cost to patients: zero.
Most states have passed some version of oversight or restrictions on pharmacy benefit managers.
In Montana, state officials have collected financial reports from pharmacy benefit managers over the past two years after passing a bill to promote transparency in these businesses.
Data from 2022 shows that rebates in Montana rarely are directly returned to people buying prescriptions. Instead, they're pocketed by the PBMs or returned to health plans.
Josh Morris, who owns three independent rural pharmacies in southwestern Montana, said his pharmacies have seen reimbursement rates for medications bought under PBM-managed plans drop.
Morris said his business routinely either breaks even or loses money. "Our plan is that once we reach a certain level of cash, that we will be out," Morris said. "As in ‘closed.'"
Frank Cote, with Montana's insurance commissioner's office, said that the state has tried to make business easier for small pharmacies but that state officials still don't control how much PBMs pay. Cote said the state will look for ways within existing rules or future legislation to support rural pharmacies.
Following Kemp's veto in Georgia, the pharmacy pay differential sparked criticism from an unusual place: within the board of the state Department of Community Health, the agency that runs the State Health Benefit Plan.
Mark Shane Mobley, a board member, said at an August meeting that independent pharmacies' pay in the state employee plan should be on par with a chain's. The PBM profit "is going to line people's pockets that are far outside of the state," said Mobley, president of Avilys Sleep & EEG, a Georgia provider of sleep disorder and electroencephalogram testing. "Our independent pharmacies, they're hiring people locally. They're taking care of the local community."
Community Health Commissioner Russel Carlson said the agency has an ongoing dialogue with CVS Caremark, the PBM handling the state employee plan medications.
"We don't have our head in the sand. We know there are some frustrations out there that exist in this space," he said. "But we acknowledge that we do have contractual responsibilities."
In Cuthbert, Bryant said she can make more profit on cake and coffee than with many medications.
Still, she's in business while a nearby CVS pharmacy closed recently. "We outcompeted them on service," Bryant said.
Montana correspondent Katheryn Houghton and senior correspondent Arthur Allen contributed to this report.
KFF found that 'many insurers are increasing premiums' and that large insurers including UnitedHealthcare and Aetna may reduced the number of plans they offer.
This article was published on Monday, October 21, 2024 in KFF Health News.
When Pam McClure learned she'd save nearly $4,000 on her prescription drugs next year, she said, "it sounded too good to be true." She and her husband are both retired and live on a "very strict" budget in central North Dakota.
By the end of this year, she will have spent almost $6,000 for her medications, including a drug to control her diabetes.
McClure, 70, is one of about 3.2 million people with Medicare prescription drug insurance whose out-of-pocket medication costs will be capped at $2,000 in 2025 because of the Biden administration's 2022 Inflation Reduction Act, according to an Avalere/AARP study.
"It's wonderful — oh my gosh. We would actually be able to live," McClure said. "I might be able to afford fresh fruit in the wintertime."
The IRA, a climate and health care law that President Joe Biden and Vice President Kamala Harris promote on the campaign trail as one of their administration's greatest accomplishments, radically redesigned Medicare's drug benefit, called Part D, which serves about 53 million people 65 and older or with disabilities. The administration estimates that about 18.7 million people will save about $7.4 billion next year alone due to the cap on out-of-pocket spending and less publicized changes.
The annual enrollment period for Medicare beneficiaries to renew or switch drug coverage or to choose a Medicare Advantage plan began Oct. 15 and runs through Dec. 7. Medicare Advantage is the commercial alternative to traditional government-run Medicare and covers medical care and often prescription drugs. Medicare's stand-alone drug plans, which cover medicines typically taken at home, are also administered by private insurance companies.
"We always encourage beneficiaries to really look at the plans and choose the best option for them," Chiquita Brooks-LaSure, who heads the Centers for Medicare & Medicaid Services, told KFF Health News. "And this year in particular it's important to do that because the benefit has changed so much."
Improvements to Medicare drug coverage required by the IRA are the most sweeping changes since Congress added the benefit in 2003, but most voters don't know about them, KFF surveys have found. And some beneficiaries may be surprised by a downside: premium increases for some plans.
CMS said Sept. 27 that nationwide the average Medicare drug plan premium fell about $1.63 a month — about 4% — from last year. "People enrolled in a Medicare Part D plan will continue to see stable premiums and will have ample choices of affordable Part D plans," CMS said in a statement.
However, an analysis by KFF, a health information nonprofit that includes KFF Health News, found that "many insurers are increasing premiums" and that large insurers including UnitedHealthcare and Aetna also reduced the number of plans they offer.
Many Part D insurers' initial 2025 premium proposals were even higher. To cushion the price shock, the Biden administration created what it calls a demonstration program to pay insurers $15 extra a month per beneficiary if they agreed to limit premium increases to no more than $35.
"In the absence of this demonstration, premium increases would certainly have been larger," Juliette Cubanski, deputy director of the Program on Medicare Policy at KFF, wrote in her Oct. 3 analysis.
Nearly every Part D insurer agreed to the arrangement. Republicans have criticized it, questioning CMS' authority to make the extra payments and calling them a political ploy in an election year. CMS officials say the government has taken similar measures when implementing other Medicare changes, including under President George W. Bush, a Republican.
In California, for example, Wellcare's popular Value Script plan went from 40 cents a month to $17.40. The Value Script plan in New York went from $3.70 a month to $38.70, a more than tenfold hike — and precisely a $35 increase.
Cubanski identified eight plans in California that raised their premiums exactly $35 a month. KFF Health News found that premiums went up for at least 70% of drug plans offered in California, Texas, and New York and for about half of plans in Florida and Pennsylvania — the five states with the most Medicare beneficiaries.
Spokespeople for Wellcare and its parent company, Centene Corp., did not respond to requests for comment. In a statement this month, Centene's senior vice president of clinical and specialty services, Sarah Baiocchi, said Wellcare would offer the Value Script plan with no premium in 43 states.
In addition to the $2,000 drug spending limit, the IRA caps Medicare copayments for most insulin products at no more than $35 a month and allows Medicare to negotiate prices of some of the most expensive drugs directly with pharmaceutical companies.
It will also eliminate one of the drug benefit's most frustrating features, a gap known as the "donut hole," which suspends coverage just as people face growing drug costs, forcing them to pay the plan's full price for drugs out-of-pocket until they reach a spending threshold that changes from year to year.
The law also expands eligibility for "extra help" subsidies for about 17 million low-income people in Medicare drug plans and increases the amount of the subsidy. Drug companies will be required to chip in to help pay for it.
Starting Jan. 1, the redesigned drug benefit will operate more like other private insurance policies. Coverage begins after patients pay a deductible, which will be no more than $590 next year. Some plans offer a smaller or no deductible, or exclude certain drugs, usually inexpensive generics, from the deductible.
After beneficiaries spend $2,000 on deductibles and copayments, the rest of their Part D drugs are free.
That's because the IRA raises the share of the bill picked up by insurers and pharmaceutical companies. The law also attempts to tamp down future drug price hikes by limiting increases to the consumer price inflation rate, which was 3.4% in 2023. If prices rise faster than inflation, drugmakers have to pay Medicare the difference.
"Before the redesign, Part D incentivized drug price increases," said Gina Upchurch, a pharmacist and the executive director of Senior PharmAssist, a Durham, North Carolina, nonprofit that counsels Medicare beneficiaries. "The way it is designed now places more financial obligations on the plans and manufacturers, pressuring them to help control prices."
Another provision of the law allows beneficiaries to pay for drugs on an installment plan, instead of having to pay a hefty bill over a short period of time. Insurers are supposed to do the math and send policyholders a monthly bill, which will be adjusted if drugs are added or dropped.
Along with big changes brought by the IRA, Medicare beneficiaries should prepare for the inevitable surprises that come when insurers revise their plans for a new year. In addition to raising premiums, insurers can drop covered drugs and eliminate pharmacies, doctors, or other services from the provider networks beneficiaries must use.
Missing the opportunity to switch plans means coverage will renew automatically, even if it costs more or no longer covers needed drugs or preferred pharmacies. Most beneficiaries are locked into Medicare drug and Advantage plans for the year unless CMS gives them a "special enrollment period."
"We do have a system that is run through private health plans," CMS chief Brooks-LaSure said. But she noted that beneficiaries "have the ability to change their plans."
But many don't take the time to compare dozens of plans that can cover different drugs at different prices from different pharmacies — even when the effort could save them money. In 2021, only 18% of Medicare Advantage drug plan enrollees and 31% of stand-alone drug plan members checked their plan's benefits and costs against competitors', KFF researchers found.
For free, unbiased help selecting drug coverage, contact the State Health Insurance Assistance Program at shiphelp.org or 1-877-839-2675.